Beryl Drugs Revenue

In the fiscal year ending March 31, 2025, Beryl Drugs had annual revenue of 211.46M INR, down -20.89%. Beryl Drugs had revenue of 39.74M in the quarter ending March 31, 2025, with 33.54% growth.

Revenue

211.46M

Revenue Growth

-20.89%

P/S Ratio

0.46

Revenue / Employee

n/a

Employees

n/a

Market Cap

96.87M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	211.46M	-55.84M	-20.89%
Mar 31, 2024	267.30M	-1.41M	-0.53%
Mar 31, 2023	268.71M	122.67M	84.00%
Mar 31, 2022	146.04M	5.11M	3.62%
Mar 31, 2021	140.93M	12.78M	9.97%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Reliance Industries	9,646.93B
HDFC Bank	2,728.47B
Tata Consultancy Services	2,553.24B
Bharti Airtel	1,729.85B
ICICI Bank	2,006.54B
State Bank of India	3,429.39B
Infosys	1,647.16B
Life Insurance Corporation of India	8,901.58B

Revenue Rankings